Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Validation of a Single-Nucleotide Polymorphism-Based Non-Invasive Prenatal Test in Twin Gestations: Determination of Zygosity, Individual Fetal Sex, and Fetal Aneuploidy.

Norwitz ER, McNeill G, Kalyan A, Rivers E, Ahmed E, Meng L, Vu P, Egbert M, Shapira M, Kobara K, Parmar S, Goel S, Prins SA, Aruh I, Persico N, Robins JC, Kirshon B, Demko ZP, Ryan A, Billings PR, Rabinowitz M, Benn P, Martin KA, Hedriana HL.

J Clin Med. 2019 Jun 28;8(7). pii: E937. doi: 10.3390/jcm8070937.

2.

Analytical Validation of a Single-Nucleotide Polymorphism-Based Donor-Derived Cell-Free DNA Assay for Detecting Rejection in Kidney Transplant Patients.

Altu─č Y, Liang N, Ram R, Ravi H, Ahmed E, Brevnov M, Swenerton R, Zimmermann B, Malhotra M, Demko ZP, Billings PR, Ryan A.

Transplantation. 2019 Feb 19. doi: 10.1097/TP.0000000000002665. [Epub ahead of print]

PMID:
30801536
3.

Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR.

Sigdel TK, Archila FA, Constantin T, Prins SA, Liberto J, Damm I, Towfighi P, Navarro S, Kirkizlar E, Demko ZP, Ryan A, Sigurjonsson S, Sarwal RD, Hseish SC, Chan-On C, Zimmermann B, Billings PR, Moshkevich S, Sarwal MM.

J Clin Med. 2018 Dec 23;8(1). pii: E19. doi: 10.3390/jcm8010019.

4.

Performance and Diagnostic Accuracy of a Urine-Based Human Papillomavirus Assay in a Referral Population.

Cuzick J, Cadman L, Ahmad AS, Ho L, Terry G, Kleeman M, Lyons D, Austin J, Stoler MH, Vibat CRT, Dockter J, Robbins D, Billings PR, Erlander MG.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1053-1059. doi: 10.1158/1055-9965.EPI-16-0960. Epub 2017 Feb 21.

5.

The role of BPTF in melanoma progression and in response to BRAF-targeted therapy.

Dar AA, Nosrati M, Bezrookove V, de Semir D, Majid S, Thummala S, Sun V, Tong S, Leong SP, Minor D, Billings PR, Soroceanu L, Debs R, Miller JR 3rd, Sagebiel RW, Kashani-Sabet M.

J Natl Cancer Inst. 2015 Feb 23;107(5). pii: djv034. doi: 10.1093/jnci/djv034.

6.

The impact of a fourteen-gene molecular assay on physician treatment decisions in non-small-cell lung cancer.

Dormady S, Broder MS, Putcha GV, Dumanois RH, DeCristofaro AH, Chang E, Billings PR, Jahan T.

Int J Clin Oncol. 2015 Feb;20(1):59-69. doi: 10.1007/s10147-014-0700-8. Epub 2014 Jun 6.

PMID:
24902933
7.

Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities.

Craig DW, O'Shaughnessy JA, Kiefer JA, Aldrich J, Sinari S, Moses TM, Wong S, Dinh J, Christoforides A, Blum JL, Aitelli CL, Osborne CR, Izatt T, Kurdoglu A, Baker A, Koeman J, Barbacioru C, Sakarya O, De La Vega FM, Siddiqui A, Hoang L, Billings PR, Salhia B, Tolcher AW, Trent JM, Mousses S, Von Hoff D, Carpten JD.

Mol Cancer Ther. 2013 Jan;12(1):104-16. doi: 10.1158/1535-7163.MCT-12-0781. Epub 2012 Nov 19.

8.

Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model.

Helzer KT, Barnes HE, Day L, Harvey J, Billings PR, Forsyth A.

Cancer Res. 2009 Oct 1;69(19):7860-6. doi: 10.1158/0008-5472.CAN-09-0801. Epub 2009 Sep 29.

9.

Beyond GINA.

Billings PR.

Nat Med. 2008 Aug;14(8):806. doi: 10.1038/nm0808-806. No abstract available.

PMID:
18685590
10.

Three barriers to innovative diagnostics.

Billings PR.

Nat Biotechnol. 2006 Aug;24(8):917-8. No abstract available.

PMID:
16900129
11.

Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests.

Berger BM, Schroy PC 3rd, Rosenberg JL, Lai-Goldman M, Eisenberg M, Brown T, Rochelle RB, Billings PR.

Clin Colorectal Cancer. 2006 Jan;5(5):338-43.

PMID:
16512992
12.

Ready for genomic medicine? Perspectives of health care decision makers.

Billings PR, Carlson RJ, Carlson J, Cain M, Wilson C, Shorett P, Everett W.

Arch Intern Med. 2005 Sep 12;165(16):1917-9. No abstract available.

PMID:
16157838
13.

Genetic nondiscrimination.

Billings PR.

Nat Genet. 2005 Jun;37(6):559-60.

PMID:
15920511
14.

The future of clinical laboratory genomics.

Billings PR, Brown MP.

MLO Med Lab Obs. 2004 Dec;36(12):8-10, 12-5; quiz 16-7. Review. No abstract available.

PMID:
15648511
15.

The changing norms of the life sciences.

Shorett P, Rabinow P, Billings PR.

Nat Biotechnol. 2003 Feb;21(2):123-5. No abstract available.

PMID:
12560827
16.

Conflicts around a study of Mexican crops.

Worthy K, Strohman RC, Billings PR.

Nature. 2002 Jun 27;417(6892):897; author reply 897-8. No abstract available.

PMID:
12087377
17.
18.

Crossing the germline.

Billings PR, Newman SA.

Genewatch. 1999 Jan;11(5-6):1, 3-4. No abstract available.

PMID:
11660624
19.

Lessons from genetic discrimination.

Billings PR.

Genet Med. 2000 Jul-Aug;2(4):207-8. No abstract available.

PMID:
11252703
20.

Applying advances in genetic medicine: where do we go from here?

Billings PR.

Healthplan. 2000 Nov-Dec;41(6):32-5. No abstract available.

PMID:
11185807
21.

Redesigning evolution?

Nader C, Herbert MR, Billings PR, Bereano PL, Hubbard R, King J, Krimsky S, Newman SA, Stabinsky D.

Science. 1999 Sep 3;285(5433):1491; author reply 1492. No abstract available.

PMID:
10498533
22.

Human germline gene modification: a dissent.

Billings PR, Hubbard R, Newman SA.

Lancet. 1999 May 29;353(9167):1873-5. No abstract available.

PMID:
10359429
23.

In utero gene therapy: the case against.

Billings PR.

Nat Med. 1999 Mar;5(3):255-6. No abstract available.

PMID:
10086370
24.

Individual, family, and societal dimensions of genetic discrimination: a case study analysis.

Geller LN, Alper JS, Billings PR, Barash CI, Beckwith J, Natowicz MR.

Sci Eng Ethics. 1996 Jan;2(1):71-88. No abstract available.

PMID:
11657787
25.

DNA on trial.

Billings PR.

N Engl J Med. 1995 Aug 31;333(9):602. No abstract available. Erratum in: N Engl J Med 1995 Nov 2;333(18):1231.

PMID:
7623922
26.

Genetic discrimination and screening for hemochromatosis.

Alper JS, Geller LN, Barash CI, Billings PR, Laden V, Natowicz MR.

J Public Health Policy. 1994 Autumn;15(3):345-58.

PMID:
7983195
27.

Screening for hemochromatosis.

Billings PR, Barash C, Geller LN, Alper JS.

N Engl J Med. 1993 Dec 30;329(27):2037; author reply 2037-8. No abstract available.

PMID:
8247088
28.

Genetic discrimination.

Billings PR.

Healthc Forum J. 1993 Sep-Oct;36(5):35-7. No abstract available.

PMID:
10171739
29.

Health care providers, insurers, and individual patients; the right to treatment; economic and policy issues.

Stoddard JC, Billings PR, Astrue MJ, Tennenbaum D, Lynch EC.

Suffolk Univ Law Rev. 1993 Winter;27(4):1499-523. No abstract available.

PMID:
11657047
30.

Applications of DNA fingerprinting.

Billings PR.

J Pediatr. 1992 Dec;121(6):989-90. No abstract available.

PMID:
1447674
31.

Conflicts, ethics, and the genome.

Billings PR, Lippman A, Wilker N.

Am J Hum Genet. 1992 Nov;51(5):1168. No abstract available.

32.

Reply to Hook and Lowden: the definition and implications of genetic discrimination.

Billings PR, Alper JS, Beckwith J, Barash CI, Natowicz MR.

Am J Hum Genet. 1992 Oct;51(4):903-5. No abstract available.

33.

The genetic analysis of human behavior: a new era?

Billings PR, Beckwith J, Alper JS.

Soc Sci Med. 1992 Aug;35(3):227-38. Review.

PMID:
1519075
34.

Discrimination as a consequence of genetic testing.

Billings PR, Kohn MA, de Cuevas M, Beckwith J, Alper JS, Natowicz MR.

Am J Hum Genet. 1992 Mar;50(3):476-82.

35.

The context of genetic screening.

Billings PR.

Yale J Biol Med. 1991 Jan-Feb;64(1):47-52. No abstract available.

36.

New techniques for physical mapping of the human genome.

Billings PR, Smith CL, Cantor CR.

FASEB J. 1991 Jan;5(1):28-34. Review.

PMID:
1846833
37.

Promotion of the human genome project.

Billings PR.

Science. 1990 Nov 23;250(4984):1071. No abstract available.

PMID:
2251496
38.

Antigen-specific and antibody-mediated growth inhibition of suppressor T cell hybridomas. Roles of H-2 and the CD3-T cell receptor-alpha/beta complex.

Kuchroo VK, Billings PR, Levine C, Martin CA, Kubo RT, Dorf ME.

J Immunol. 1990 Aug 15;145(4):1059-65.

PMID:
2143205
39.

Clustering of cytokine genes on mouse chromosome 11.

Wilson SD, Billings PR, D'Eustachio P, Fournier RE, Geissler E, Lalley PA, Burd PR, Housman DE, Taylor BA, Dorf ME.

J Exp Med. 1990 Apr 1;171(4):1301-14.

40.

Transfusions and the acquired immunodeficiency syndrome (AIDS)

Billings PR.

Ann Intern Med. 1989 Nov 1;111(9):767. No abstract available.

PMID:
2802438
41.

Expression of CD3-associated antigen-binding receptors on suppressor T cells.

Kuchroo VK, Steele JK, Billings PR, Selvaraj P, Dorf ME.

Proc Natl Acad Sci U S A. 1988 Dec;85(23):9209-13.

42.

Comparison of fibroblast and T-cell activation genes.

Burd PR, Rollins BJ, Wilson SD, Billings PR, Stiles CD, Dorf ME.

Cell Immunol. 1988 Sep;115(2):481-3. No abstract available.

PMID:
3261640
43.

The expression and regulation of a potential lymphokine gene (TCA3) in CD4 and CD8 T cell clones.

Wilson SD, Burd PR, Billings PR, Martin CA, Dorf ME.

J Immunol. 1988 Sep 1;141(5):1563-70.

PMID:
2457620
44.

Preventing tampering with prescriptions: the Marton method.

Billings PR.

Ann Intern Med. 1988 Apr;108(4):637. No abstract available.

PMID:
3348575
45.

Cloning and characterization of a novel T cell activation gene.

Burd PR, Freeman GJ, Wilson SD, Berman M, DeKruyff R, Billings PR, Dorf ME.

J Immunol. 1987 Nov 1;139(9):3126-31.

PMID:
3499466
46.

Hypertension and the genetics of red cell membrane abnormalities.

Motulsky AG, Burke W, Billings PR, Ward RH.

Ciba Found Symp. 1987;130:150-66. Review.

PMID:
2450724
47.

Physicians poor at prevalence and positive predictive value.

Billings PR, Bernstein MS.

JAMA. 1985 Sep 6;254(9):1173-4. No abstract available.

PMID:
4021056
48.

Hypercoagulability, hyperlipidemia, and serum antiproteases.

Billings PR.

Ann Intern Med. 1985 May;102(5):724. No abstract available.

PMID:
3872619

Supplemental Content

Loading ...
Support Center